Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 13668-465

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 13668-465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (290c7038 Fd8c 4250 8569 99793e8864ea 01)

Chemical structure of Lurasidone Hydrochloride, illustrating its molecular arrangement with indicated atoms and bonds including the hydrochloride component.*

FDA Label Image

Image (290c7038 Fd8c 4250 8569 99793e8864ea 02)

A pharmacokinetic impact chart showing the effect of various interacting drugs on Lurasidone Hydrochloride. The graph depicts fold change with 90% confidence intervals relative to Lurasidone alone for Cmax and AUC parameters with drugs classified as strong CYP3A4 inhibitors, moderate CYP3A4 inhibitors, and strong CYP3A4 inducers.*

FDA Label Image

Image (290c7038 Fd8c 4250 8569 99793e8864ea 03)

A horizontal error bar chart displaying the fold change and 90% confidence interval of pharmacokinetic parameters (Cmax, AUC, and Ctrough) for various interacting drugs relative to the drug alone. The drugs include Digoxin, Midazolam, Ethinyl Estradiol, Noregestromin, and Lithium, plotted along the x-axis as change relative to interactive drug alone.*

FDA Label Image

Figure 3: Impact Of Other Patient Factors On Lurasidone Hydrochloride Pharmacokinetics (290c7038 Fd8c 4250 8569 99793e8864ea 04)

A pharmacokinetic chart showing fold change and 90% confidence intervals for Lurasidone Hydrochloride comparing Cmax and AUC values in populations with varying degrees of renal and hepatic impairment, as well as gender and race subgroups. The x-axis represents change relative to reference, ranging from 0 to 6 fold change.*

FDA Label Image

Image (290c7038 Fd8c 4250 8569 99793e8864ea 05)

FDA Label Image

Image (290c7038 Fd8c 4250 8569 99793e8864ea 06)

A table listing the coating materials and ingredients for Lurasidone Hydrochloride film-coated tablets by strength. Tablets of 20 mg, 40 mg, and 120 mg strengths use Opadry white containing hypromellose, titanium dioxide, and macrogol/polyethylene glycol. The 80 mg tablet uses Opadry green with hypromellose, titanium dioxide, macrogol/polyethylene glycol, iron oxide yellow, and FD&C Blue #2/indigo carmine aluminum lake.*

FDA Label Image

Logo (290c7038 Fd8c 4250 8569 99793e8864ea 07)

FDA Label Image

Container Label (290c7038 Fd8c 4250 8569 99793e8864ea 08)

Label for Lurasidone Hydrochloride Tablets, 20 mg film-coated tablets, oral administration. The label indicates a quantity of 500 tablets and includes storage instructions, pharmacist dispensing guidance, the NDC number 13668-464-05, and the labeler Torrent Pharmaceuticals Limited.*

FDA Label Image

Container Label (290c7038 Fd8c 4250 8569 99793e8864ea 09)

Packaging label for Lurasidone Hydrochloride Tablets 40 mg, film-coated oral tablets. The label indicates a quantity of 500 tablets, NDC 13668-465-05, and is labeled for prescription use only. It includes storage instructions and directions for the pharmacist to dispense the Medication Guide to each patient. The labeler is Torrent Pharmaceuticals Limited.*

FDA Label Image

Container Label (290c7038 Fd8c 4250 8569 99793e8864ea 10)

Lurasidone Hydrochloride Tablets 80 mg film-coated oral tablets label. The package contains 500 tablets with a National Drug Code (NDC) 13668-466-05. The label includes storage instructions, pharmacist dispensing guidance, and the labeler Torrent Pharmaceuticals Limited.*

FDA Label Image

Container Label (290c7038 Fd8c 4250 8569 99793e8864ea 11)

Lurasidone Hydrochloride Tablets 120 mg film-coated oral tablets label for a bottle containing 500 tablets by Torrent Pharmaceuticals Limited. The label includes storage instructions, dosage form, strength, quantity, and NDC number 13668-467-05. The label states Rx only and includes pharmacist dispensing guidance and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.